Abstract
Platelet-derived growth factor (PDGF) and transforming growth factor-β (TGF-β) have been suggested to play important roles in wound healing. We investigated the effect of TGF-β1 on the mitogenic and chemotactic activities of PDGF A-chain homodimer (PDGF-AA) and B-chain homodimer (PDGF-BB) in primary cultures of human skin fibroblasts. TGF-β1 inhibited the growth-promoting activity of both PDGFs. Proliferative responses to basic fibroblast growth factor and epidermal growth factor were also restricted by TGF-β1. A Boyden chamber chemotaxis assay revealed that the chemotactic migration to PDGF-AA was inhibited by TGF-β1 pretreatment, but in contrast, the response to PDGF-BB was not affected by the same treatment. Western blot analysis showed that TGF-β1 downregulated PDGF α-receptors, but not β-receptors, indicating that the isoform-specific inhibition of chemotaxis is related to differential effects of TGF-β1 on PDGF receptor expression. The present findings suggest that TGF-β1 may act antagonistically towards PDGFs in humans under certain conditions, and this antagonistic nature of TGF-β1 must be considered when it is applied to human wounds as a therapeutic agent.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Soma, Y., Mizoguchi, M., Yamane, K. et al. Specific inhibition of human skin fibroblast chemotaxis to platelet-derived growth factor A-chain homodimer by transforming growth factor-β1. Arch Dermatol Res 293, 609–613 (2002). https://doi.org/10.1007/s00403-001-0279-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-001-0279-6